CD8A and neoplasm: However, clinical trials have revealed that immunotherapy alone may not achieve a considerable and persistent therapeutic response.[26] In our study, we found that the infiltration of CD8+ T cells significantly increased in the tumor, lymph node, and spleen when treated with N@VP in combination with CDRT (Figure 5e).